Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Item
http://www.wikidata.org/entity/Q31983905
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen.A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.Haematopoietic growth factors in children with neutropenia.Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.Neutropenia and G-CSF in lymphoproliferative diseases.Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumourA study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.Small Split Doses of CD34+ Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy.Front-line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group.
P2860

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report.

Item
http://www.wikidata.org/entity/Q31983905
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prospective randomized trial b ...... hildren's cancer group report.
@ast
Prospective randomized trial b ...... hildren's cancer group report.
@en
type
label
Prospective randomized trial b ...... hildren's cancer group report.
@ast
Prospective randomized trial b ...... hildren's cancer group report.
@en
prefLabel
Prospective randomized trial b ...... hildren's cancer group report.
@ast
Prospective randomized trial b ...... hildren's cancer group report.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Prospective randomized trial b ...... hildren's cancer group report.
@en
P2093
P304
P31
P356
10.1097/00043426-200101000-00008
P433
P478
P577
P698